Crestline Management LP Invests $4.20 Million in Healthpeak Properties, Inc. (NYSE:DOC)

Crestline Management LP bought a new position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 207,118 shares of the real estate investment trust's stock, valued at approximately $4,198,000.

A number of other large investors have also recently modified their holdings of DOC. Principal Financial Group Inc. grew its holdings in shares of Healthpeak Properties by 2,113.5% during the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock worth $367,575,000 after acquiring an additional 17,314,572 shares during the period. Norges Bank bought a new stake in shares of Healthpeak Properties during the fourth quarter valued at approximately $166,804,000. Long Pond Capital LP purchased a new stake in Healthpeak Properties in the fourth quarter worth $86,885,000. JPMorgan Chase & Co. raised its holdings in Healthpeak Properties by 23.2% in the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock worth $493,115,000 after purchasing an additional 4,056,931 shares in the last quarter. Finally, Northern Trust Corp lifted its position in Healthpeak Properties by 32.6% during the fourth quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock valued at $213,367,000 after buying an additional 2,590,530 shares during the period. Institutional investors own 93.57% of the company's stock.

Healthpeak Properties Stock Performance

Shares of DOC stock traded up $0.11 during trading hours on Friday, reaching $17.50. The company had a trading volume of 4,245,778 shares, compared to its average volume of 4,950,215. The firm has a market cap of $12.16 billion, a PE ratio of 50.00, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05. The business has a fifty day moving average price of $19.08 and a 200-day moving average price of $20.26. Healthpeak Properties, Inc. has a one year low of $17.21 and a one year high of $23.26. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The business had revenue of $702.89 million during the quarter, compared to analyst estimates of $690.76 million. During the same period in the previous year, the business earned $0.45 EPS. The company's quarterly revenue was up 15.9% compared to the same quarter last year. Sell-side analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently declared a dividend, which was paid on Wednesday, April 30th. Shareholders of record on Friday, April 18th were paid a dividend of $0.1017 per share. The ex-dividend date was Thursday, April 17th. This represents a dividend yield of 6.5%. Healthpeak Properties's dividend payout ratio is currently 305.00%.

Analyst Upgrades and Downgrades

DOC has been the subject of a number of recent research reports. StockNews.com cut shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Thursday, May 1st. Wedbush dropped their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Robert W. Baird reduced their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Morgan Stanley raised Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price on the stock in a report on Wednesday, January 15th. Finally, Argus restated a "buy" rating and set a $25.00 price target on shares of Healthpeak Properties in a report on Tuesday, April 29th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat.com, Healthpeak Properties presently has a consensus rating of "Moderate Buy" and a consensus target price of $23.42.

Insider Activity

In other Healthpeak Properties news, CEO Scott M. Brinker bought 11,337 shares of Healthpeak Properties stock in a transaction on Monday, April 28th. The stock was acquired at an average cost of $17.68 per share, with a total value of $200,438.16. Following the completion of the acquisition, the chief executive officer now owns 201,863 shares in the company, valued at approximately $3,568,937.84. This represents a 5.95 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director John T. Thomas purchased 4,200 shares of the firm's stock in a transaction on Monday, April 28th. The stock was acquired at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the transaction, the director now directly owns 813,566 shares of the company's stock, valued at approximately $14,514,017.44. This trade represents a 0.52 % increase in their position. The disclosure for this purchase can be found here. Insiders own 0.23% of the company's stock.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.